Biologics is an international, peer-reviewed, open access journal on all areas of biologics derived from both novel and established biotechnologies, published quarterly online by MDPI.
  • Open Access— free for readers, with article processing charges (APC) paid by authors or their institutions.
  • Rapid Publication: first decisions in 16 days; acceptance to publication in 5.8 days (median values for MDPI journals in the second half of 2022).
  • Recognition of Reviewers: APC discount vouchers, optional signed peer review, and reviewer names published annually in the journal.
  • Biologics is a companion journal of JCM.
Add your e-mail address to receive forthcoming issues of this journal:
Topic in Biologics, Biology, MPs, Pathogens, Vaccines
Global Analysis of SARS-CoV-2 Serology, Part 2 Topic Editors: Ger Rijkers, Jean-Luc Murk
Deadline: 31 December 2023
Special Issue in Biologics
Biopharmaceutics and Biologics for Medical Imaging Applications Guest Editor: Carsten Hoeltke
Deadline: 30 June 2023
Special Issue in Biologics
Novel Vaccine Technologies and Platforms to Protect from Infectious Diseases Guest Editors: Alexander Zakhartchouk, Sams Sadat
Deadline: 15 October 2023
Special Issue in Biologics
Anti-SARS-CoV-2/COVID-19 Drugs and Vaccines - Part II Guest Editors: Vasso Apostolopoulos, Majid Davidson
Deadline: 20 December 2023
Back to TopTop